Related Experiment Video
Updated: May 20, 2026

Simultaneous Electrical and Mechanical Stimulation to Enhance Cells' Cardiomyogenic Potential
Published on: January 18, 2019
β-Adrenergic receptor stimulation causes cardiac hypertrophy via a Gβγ/Erk-dependent pathway
Marie Vidal1, Thomas Wieland, Martin J Lohse
1Institute of Pharmacology and Toxicology, University of Würzburg, Versbacher Strasse 9, 97078 Würzburg, Germany.
Aims:
Activation of the β(1)-adrenergic receptor and its G protein, G(s), induces cardiac hypertrophy. However, activation of classic Gα(s) effectors, adenylyl cyclases (AC) and protein kinase A, is not sufficient for induction of hypertrophy, which suggests the involvement of additional pathway(s) activated by G(s). Recently, we discovered that βγ subunits of G(q) induce phosphorylation of the extracellular regulated kinases 1 and 2 (Erk1/2) at threonine188 and thereby induce hypertrophy. Here we investigated whether β-adrenergic receptors might also induce cardiac hypertrophy via Erk(Thr188) phosphorylation.
Methods And Results:
β-Adrenergic receptor activation induced Erk(Thr188) phosphorylation in mouse hearts and in neonatal cardiomyocytes. Inhibition of Erk1/2 or overexpression of Erk(Thr188) phosphorylation-deficient mutants (Erk2(T188A) and Erk2(T188S)) significantly attenuated β-adrenergic cardiomyocyte hypertrophy in vitro. Erk activity was stimulated by both isoproterenol and the direct AC activator forskolin, but only isoproterenol induced Erk(Thr188) phosphorylation. Erk(Thr188) phosphorylation required Gβγ released from G(s) and was prevented by Gβγ inhibition. Similarly, isoproterenol, but not forskolin, induced nuclear accumulation of Erk and cardiomyocyte hypertrophy. Long-term application of isoproterenol in mice caused left ventricular hypertrophy and cardiac remodelling, and this was reduced in Erk2(T188S) transgenic mice, supporting the physiological relevance of Erk(Thr188) phosphorylation.
Conclusions:
Activation of G(s) by β-adrenergic receptors leads to (i) canonical Erk1/2 activation via AC, and (ii) release of Gβγ, which then associates with activated Erk1/2 and induces Erk(Thr188) phosphorylation, causing nuclear accumulation of Erk and ultimately cardiomyocyte hypertrophy. These findings reveal a new pathway critically involved in β-adrenergically mediated cardiac hypertrophy and may yield new therapeutic strategies against hypertrophic remodelling.
Insights
Beta-adrenergic receptor activation induces cardiac hypertrophy through a novel pathway involving G protein G(s) and extracellular signal-regulated kinases (Erk). This Erk(Thr188) phosphorylation is critical for hypertrophic remodeling and may offer new therapeutic targets.
Area of Science:
- Cardiology
- Molecular Biology
- Cell Signaling
Background:
- Beta-1 adrenergic receptor and G(s) protein activation induce cardiac hypertrophy.
- Canonical G(s) effectors (adenylyl cyclase and protein kinase A) are insufficient for hypertrophy.
- G(q) protein βγ subunits induce cardiac hypertrophy via extracellular signal-regulated kinases (Erk1/2) phosphorylation at threonine188.
Purpose of the Study:
- Investigate if β-adrenergic receptors induce cardiac hypertrophy via Erk(Thr188) phosphorylation.
- Elucidate the signaling pathway linking β-adrenergic receptors to Erk(Thr188) phosphorylation and cardiac hypertrophy.
Main Methods:
- Utilized mouse hearts and neonatal cardiomyocytes.
- Employed Erk1/2 inhibition and Erk2(T188A/T188S) phosphorylation-deficient mutants.
- Administered isoproterenol and forskolin (adenylyl cyclase activator).
- Assessed Erk(Thr188) phosphorylation, nuclear Erk accumulation, and cardiomyocyte hypertrophy.
- Investigated the role of Gβγ subunits.
- Conducted long-term in vivo studies with Erk2(T188S) transgenic mice.
Main Results:
- β-Adrenergic receptor activation induced Erk(Thr188) phosphorylation in cardiac cells and mouse hearts.
- Erk1/2 inhibition or Erk2(T188A/T188S) mutants attenuated β-adrenergic cardiomyocyte hypertrophy.
- Isoproterenol, but not forskolin, induced Erk(Thr188) phosphorylation and nuclear Erk accumulation.
- Erk(Thr188) phosphorylation required Gβγ released from G(s).
- Long-term isoproterenol treatment caused cardiac hypertrophy and remodeling in mice, which was reduced in Erk2(T188S) mice.
Conclusions:
- β-Adrenergic receptor activation of G(s) triggers both canonical Erk1/2 activation via adenylyl cyclase and Gβγ release.
- Released Gβγ associates with Erk1/2, inducing Erk(Thr188) phosphorylation, nuclear translocation, and cardiomyocyte hypertrophy.
- This pathway is critical for β-adrenergically mediated cardiac hypertrophy and presents potential therapeutic targets for hypertrophic remodeling.
Related Concept Videos
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
GPCRs Regulate Adenylyl Cylase Activity
Two...
Adrenergic Receptors (Adrenoceptors): Classification
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...
Cellular Adaptation II: Hypertrophy
cAMP-dependent Protein Kinase Pathways
Antihypertensive Drugs: Action of β1 Blockers

